Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.550
-0.020 (-1.27%)
Dec 5, 2025, 4:00 PM EST - Market closed
Autolus Therapeutics Employees
As of December 31, 2024, Autolus Therapeutics had 650 total employees, including 647 full-time and 3 part-time employees. The number of employees increased by 179 or 38.00% compared to the previous year.
Employees
650
Change (1Y)
179
Growth (1Y)
38.00%
Revenue / Employee
$78,658
Profits / Employee
-$345,849
Market Cap
412.52M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AUTL News
- 4 days ago - Autolus Therapeutics Appoints Ryan Richardson to Board of Directors - GlobeNewsWire
- 10 days ago - Why Is Autolus Therapeutics Stock Trading Higher On Tuesday? - Benzinga
- 10 days ago - NICE Recommends AUCATZYL® (obecabtagene autoleucel) as a Treatment Option for Adult Patients (≥26 years) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)¹ - GlobeNewsWire
- 21 days ago - Autolus Therapeutics: Trading At Cash Is Not Justified With This Pipeline - Seeking Alpha
- 22 days ago - Autolus Therapeutics to Participate in the Jefferies Global Healthcare Conference in London - GlobeNewsWire
- 23 days ago - Autolus Therapeutics plc (AUTL) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 23 days ago - Autolus Therapeutics Reports Third Quarter 2025 Financial Results and Business Updates - GlobeNewsWire
- 4 weeks ago - Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2025 - GlobeNewsWire